T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
726
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $76M | 0.01% |
1,931,562
+1,264,013
| +189% | +$47.2M |
|
727
Amphenol
APH
$204B
| $75.9M | 0.01% |
3,459,748
-92,240
| -3% | -$2.03M |
|
728
Cognizant
CTSH
$26.7B
| $75.4M | 0.01% |
1,062,285
-21,660
| -2% | -$1.58M |
|
|
OAK
729
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $75.3M | 0.01% |
1,789,380
+197,338
| +12% | +$8.73M |
|
730
Phillips 66
PSX
$92.8B
| $75.3M | 0.01% |
744,759
-33,258
| -4% | -$3.16M |
|
|
WRI
731
DELISTED
Weingarten Realty Investors
WRI
| $74.9M | 0.01% |
2,279,368
-65,355
| -3% | -$2.12M |
|
732
Preferred Bank
PFBC
$1.28B
| $74.6M | 0.01% |
1,269,389
-60,753
| -5% | -$3.69M |
|
733
Scholastic
SCHL
$784M
| $73.4M | 0.01% |
1,829,093
+242,456
| +15% | +$9.41M |
|
734
Valero Energy
VLO
$98.7B
| $73.3M | 0.01% |
797,198
-44,922
| -5% | -$3.71M |
|
735
MaxLinear
MXL
$6.95B
| $73.1M | 0.01% |
2,767,388
+263,909
| +11% | +$6.59M |
|
736
CubeSmart
CUBE
$9.4B
| $72.5M | 0.01% |
2,508,578
+447,062
| +22% | +$12.5M |
|
737
HEICO Corp Class A
HEI.A
$38.1B
| $72.5M | 0.01% |
1,790,680
+12,008
| +0.7% | +$470K |
|
|
TCO
738
DELISTED
Taubman Centers Inc.
TCO
| $72.4M | 0.01% |
1,106,776
-868,373
| -44% | -$47.7M |
|
|
BFS
739
Saul Centers
BFS
$865M
| $72.3M | 0.01% |
1,170,188
-40,359
| -3% | -$2.53M |
|
|
REVG
740
DELISTED
REV Group
REVG
| $72.2M | 0.01% |
2,219,703
-9,189
| -0.4% | -$252K |
|
741
Huazhu Hotels Group
HTHT
$12.5B
| $72M | 0.01% |
1,993,552
+389,140
| +24% | +$12.3M |
|
742
Norfolk Southern
NSC
$75.9B
| $71.5M | 0.01% |
493,716
-14,910
| -3% | -$2M |
|
743
Dollar Tree
DLTR
$24.9B
| $71.2M | 0.01% |
663,425
-14,000
| -2% | -$1.37M |
|
744
Cognex
CGNX
$10.4B
| $71.1M | 0.01% |
1,162,850
-333,276
| -22% | -$21.2M |
|
745
Kosmos Energy
KOS
$1.51B
| $71.1M | 0.01% |
10,378,292
+804,249
| +8% | +$6.13M |
|
746
Moody's
MCO
$84.6B
| $70.7M | 0.01% |
479,004
-2,373
| -0.5% | -$348K |
|
|
BERY
747
DELISTED
Berry Global Group, Inc.
BERY
| $70.7M | 0.01% |
1,311,986
-10,706
| -0.8% | -$582K |
|
|
DERM
748
DELISTED
Dermira, Inc.
DERM
| $70.3M | 0.01% |
2,529,034
+122,666
| +5% | +$3.25M |
|
|
HMSY
749
DELISTED
HMS Holdings Corp.
HMSY
| $70.3M | 0.01% |
4,148,434
-945,879
| -19% | -$16.6M |
|
750
Ionis Pharmaceuticals
IONS
$9.28B
| $69.8M | 0.01% |
1,388,578
+264,678
| +24% | +$14.5M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.